Skip to main content
logo
Aldeyra Therapeutics logo
Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
0.7001
-0.0372 (-5.05%)
At close: Oct 16, 2026, 4:00 PM EDT
0.7500
+0.0499 (7.13%)
After-hours: Oct 16, 2026, 4:44 PM EDT

Aldeyra Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
42312297206408232
Market Cap Growth
-86.57%4.88%43.92%-49.34%75.40%-12.74%
Enterprise Value
-325224079260132
Last Close Price
0.745.184.993.516.964.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-16.3213.27---
PB Ratio
1.177.044.181.722.701.13
P/TBV Ratio
1.177.044.181.722.701.13

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.350.220.130.110.08
Net Debt / Equity Ratio
-1.19-1.23-1.21-1.06-1.05-0.43
Net Debt / EBITDA Ratio
1.891.561.432.992.541.59
Net Debt / FCF Ratio
2.041.641.994.192.792.09
Quick Ratio
4.672.525.446.4211.568.90
Current Ratio
4.912.585.606.6411.7919.77
Return on Equity (ROE)
-49.48%-58.73%-58.54%-27.73%-34.77%-43.56%
Return on Assets (ROA)
-22.70%-24.95%-29.71%-16.23%-18.91%-22.20%
Return on Capital Employed (ROCE)
-63.50%-79.70%-69.90%-33.90%-37.80%-25.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-51.83%-10.86%-18.80%-18.18%-15.22%-24.86%
FCF Yield
-49.56%-10.70%-14.54%-14.69%-13.90%-18.32%
Buyback Yield / Dilution
-0.79%-0.96%-0.92%-0.92%-8.08%-59.11%
SEC Filings: 10-K · 10-Q